XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Cash Proceeds and Aggregate Fair Value of Stock Options Exercised In addition, there were no stock options exercised during the years ended December 31, 2022, 2021 and 2020.
Schedule of Stock Options Activity
The following table sets forth a summary of the stock option activity, weighted-average exercise prices and options outstanding as of December 31, 2022, 2021 and 2020 as follows (in thousands, except per share amounts and years):
 For the years ended December 31,
 202220212020
 Common
Stock
Options
Weighted
Average
Exercise
Price
Common Stock OptionsWeighted Average Exercise PriceCommon
Stock
Options
Weighted
Average
Exercise
Price
Outstanding at beginning of year:$22.35 $22.35 $22.35 
Granted— $— — $— — $— 
Exercised— $— — $— — $— 
Expired or forfeited(5)$22.35 — $— — $— 
Outstanding at end of year:— $— $22.35 $22.35 
Schedule of Vesting Activity of Restricted Stock Units
A summary of the vesting activity of restricted stock unit awards, with the respective fair value of the awards, is as follows (in thousands):
 For the year ended December 31,
 202220212020
Restricted stock awards vested401 317 208 
Fair value of awards vested$2,524 $3,434 $837 
Schedule of Fully-vested Common Stocks Issued to Non-employee Directors
A summary of the fully-vested common stock the Company issued to its six non-employee directors, in connection with its non-employee director compensation plan, is as follows (in thousands):
 For the year ended December 31,
 202220212020
Awards issued70 51 68 
Grant date fair value of awards issued$450 $525 $326 
Schedule of Non-vested Restricted Share Units
A summary of the Company's outstanding, non-vested restricted share units is as follows (in thousands, except per share amounts and years):
For the year ended December 31,
202220212020
UnitsWeighted
Average
Grant-Date
Fair Value
UnitsWeighted
Average
Grant-Date
Fair Value
UnitsWeighted
Average
Grant-Date
Fair Value
Outstanding at beginning of period:1,208 $7.96 1,076 $7.41 559 $16.92 
Granted687 $7.59 528 $10.07 782 $3.79 
Released(401)$6.63 (317)$10.77 (208)$18.71 
Forfeited(79)$14.23 (79)$8.82 (57)$9.62 
Outstanding at end of period:1,415 $6.66 1,208 $7.96 1,076 $7.41 
Schedule of Performance Shares Units Activity
A summary of the Company's PRSU activity is presented as follows (in thousands, except per share amounts and years):
 For the year ended December 31,
202220212020
 UnitsWeighted
Average
Grant-Date
Fair Value
UnitsWeighted
Average
Grant-Date
Fair Value
UnitsWeighted
Average
Grant-Date
Fair Value
Outstanding at beginning of period:388 $10.07 333 $8.84 260 $16.77 
Granted341 $6.55 189 $12.59 292 $3.68 
Performance condition adjustments, net(376)$7.71 (56)$9.27 (99)$3.82 
Released(73)$5.17 (78)$8.15 (120)$17.29 
Forfeited— $— — $— — $— 
Outstanding at end of period:280 $9.96 388 $10.07 333 $8.84